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Nosocomial infections dramatically increase mortality rates on intensive care units (ICUs), and Staphylococcus aureus is one of the most important pathogens involved in these infections, accounting for up to 30% of cases. [1] [2] [3] In addition, nosocomial pathogens often acquire a high level of antibiotic resistance. Methicillin-resistant S. aureus (MRSA) was first reported in 1961 4 and subsequently spread throughout hospitals worldwide. 5 The prevalence of MRSA differs strongly between countries. 6 Colonization with S. aureus is a major risk factor for developing a nosocomial infection. 7 The risk of becoming colonized during a stay in an ICU is dependent on a number of variables, among which are colonization pressure 8 and antibiotic use. [9] [10] [11] [12] [13] Infection-control measures have been implemented worldwide to prevent the transmission of MRSA, but there is no clear consensus concerning the importance of each independent measure. [14] [15] [16] [17] [18] Possible sources for acquisition of S. aureus include other patients, health care workers (HCWs), and the ICU environment. [19] [20] [21] [22] [23] [24] [25] [26] [27] Endogenous reservoirs of S. aureus could also play an important role in cases that may give the false impression of being due to acquisition of S. aureus by ICU patients. 28 Consensus on the importance of patient-to-patient cross-transmission of S. aureus has not been reached, because study results have been highly variable. 23, 24, [29] [30] [31] [32] These results were mainly obtained in single-center studies that assessed MRSA only. It is unclear whether the considerable variations in rates of acquisition and cross-transmission are attributable to differences in S. aureus prevalence and in infection-control measures or merely reflect variations in study protocol.
The aim of the current study was to evaluate the baseline acquisition and cross-transmission rates of both methicillinsusceptible S. aureus (MSSA) and MRSA in different ICUs. To this end, we performed a multicenter study that compared the prevalence, acquisition, and spread of MSSA and MRSA in 6 European ICUs. Patient-to-patient cross-transmission was studied by genotyping of all strains with multilocus variable number of tandem repeats analysis (MLVA) and spa typing. [33] [34] [35] [36] MSSA and MRSA were analyzed separately because of the important differences in general epidemiology between the 2 groups of strains.
methods
Setting. The study was begun in 2006 at 6 ICUs in 6 university and teaching hospitals (with a total of 77 beds) and was performed for a period of 3 months per center. The centers were located in The Netherlands, France, Portugal, Spain, Italy, and Greece. The following information on each ICU was registered: number of beds, amount of hand disinfectant used per year, the proportion of beds in private rooms and in the open ICU, and available isolation treatment options.
Center 1 is an 18-bed ICU with 6 isolation rooms with negative air pressure. Four isolation rooms have an antechamber for changing and disinfection of personnel in cases of patient isolation due to infection with resistant pathogens (including MRSA). The other 12 beds are in a single large room. Center 2 has 15 private rooms without an antechamber. Nurses are cohorted during the daytime. Center 3 has a 14-bed open ICU with no cohorting of nurses. Center 4 has a 15-bed open ICU and no cohorting of nurses. Center 5 is an 8-bed ICU without an isolation room, and nurses are not cohorted. Center 6 is a 7-bed ICU without nurse cohorting. Centers 3, 4, 5, and 6 do not possess or rarely use isolation rooms.
Microbiological samples. All patients who were admitted to the ICUs within the study period were included in the study. Nasal and perineal swab samples were obtained within 48 hours after admission and at discharge from the ICU. During ICU stay, all patients had nasal and perineal swab samples obtained twice per week on fixed days. Clinical samples were also collected for analysis. Samples were collected and processed by the dedicated investigator. Swab samples were cultured for 24 hours at 37ЊC in 4 mL of trypsin soy broth containing aztreonam at a concentration of 5 mg/L. Samples were plated on mannitol salt agar and blood agar plates and were incubated for 48 hours at 37ЊC. Species identification was performed by standard methods. All S. aureus isolates were transported to the principal investigator on Amies transport swabs and kept at 4ЊC.
All strains were examined by a triplex polymerase chain reaction (PCR) for 16S ribosomal RNA and nuc and mecA genes. 37 DNA was isolated using a Nucleospin Tissue Kit (Machinery-Nagel) according to the manufacturer's protocol.
Genotyping. All isolates were genotyped by the principal investigator in Utrecht, The Netherlands, using MLVA and spa typing. MLVA was performed by PCR of 6 variable number tandem repeats. 38, 39 The analysis was performed as described elsewhere. 40 Spa typing was performed using 5 -ACGAGTAGT-GCCCTTTGCTT and 3 -GCTCAAGCACCAAAAGAGGA PCR primers (Invitrogen) or 5 -TAAAGACGATCCTTCGGT-GAGC and 3 -CAGCAGTAGTGCCGTTTGCTT PCR primers (Isogen Life Sciences). Subsequent DNA sequencing was performed using the chain termination method (Baseclear). Bionumerics (Applied Maths) was used to analyze obtained sequences and to assign spa types. Novel spa types were submitted online to the Ridom database. 41 Prevalence and acquisition. The prevalence of S. aureus was defined as the percentage of patients with at least 1 swab sample positive for S. aureus during the ICU stay. Acquisition of S. aureus was determined for patients who had test results that were negative for S. aureus at admission to the ICU (atrisk patients) and was classified as ICU acquired if the first sample positive for S. aureus was obtained at least 48 hours after ICU admission. The acquisition rate was defined as the percentage of at-risk patients who acquired S. aureus and remained hospitalized in the ICU long enough to have at least 1 follow-up swab sample obtained for culture.
Patient information. Patient information obtained included date of birth, date of admission to and discharge from the ICU, and antibiotic treatment regimen. The ICU length of stay (LOS) was calculated for each patient. Length of stay at risk (LOS at risk) was defined as the number of days prior to acquisition of S. aureus.
Infection-control measures. To estimate the level of hand hygiene compliance, the total amount of hand disinfectant used during the study period was determined. The number of hand disinfectant doses used per bed per day was calculated by dividing the total amount used daily by the number of beds. One hand disinfectant dose was defined as 3 mL of disinfectant for all types (soap, liquid, and gel). Private room and isolation treatment procedures were classified according to 2 levels of treatment (ICU set-up) as follows: 1, all patients were treated in private rooms; 2, patients were treated in an open-bay setting.
Colonization pressure. Mean colonization pressure was defined as the mean percentage of patients colonized with S. aureus during the entire study period. Preacquisition colonization pressure was defined as the mean percentage of patients colonized with S. aureus during the 3 days preceding acquisition. For the analysis of MSSA and MRSA acquisition, only MSSA colonization pressure and MRSA colonization pressure, respectively, were assessed. Antibiotic pressure. Antibiotic pressure was evaluated by the total number of defined daily doses (DDDs) of antibiotics administered to a patient during their total stay. The mean number of DDDs was calculated by dividing the total number of administered DDDs by the length of stay. The mean number of DDDs administered per day per 1000 patient-days was calculated to compare antibiotic pressure between centers.
Cross transmission. Bacterial transmission was considered to have occurred if a patient acquired a strain that was carried by another patient within the 2 weeks preceding acquisition. Isolates were considered to be genetically highly related if MLVA and spa type were identical or if isolates differed only in a single locus in MLVA or had a highly related spa repeat sequence.
Statistical analysis. All statistical analyses were performed using the SPSS software, version 12.0.2 (SPSS). Bivariate analyses were performed using the Pearson x 2 cross-tabulation or the Student t test (for independent samples). Data from center 1 were discarded in all analyses of MRSA acquisition because no MRSA strains were isolated in this center during the study period. Statistical significance was set at .
The total number of patients admitted to the participating ICUs in the study period was 629 (Table 1 ). Of these, 224 patients (36%) were colonized with S. aureus on at least 1 occasion during their stay in the ICU; 49 (22%; range, 0%-46%) of these 224 patients carried MRSA.
A total of 316 patients were not colonized with S. aureus at admission to the ICU and remained hospitalized in the ICU long enough to assess acquisition of S. aureus with at least 1 follow-up swab sample. Of these at-risk patients, 45 (14%; range, 0%-20%) acquired S. aureus (Table 1) during the ICU stay; 14 became colonized with MRSA (4% of atrisk patients; range, 0%-12%). The remaining 271 patients were not colonized with S. aureus during the ICU stay.
Variables considered as possible explanations for the differences in acquisition included antibiotic pressure on the ICU prior to acquisition of S. aureus, length of stay (LOS) prior to acquisition of S. aureus, colonization pressure, number of beds per nurse, hand disinfectant used per bed per day, and ICU setting (private-room treatment vs open ICU treatment).
The amount of antibiotics used on the ICUs ranged from 0.8 to 3.2 DDDs (Table 2) . Patients who acquired MSSA or MRSA did not receive a larger quantitiy of antibiotics prior to acquisition than did patients who did not acquire S. aureus ( for MSSA; for MRSA) ( Table 3 ). The mean number of beds P p .005 per nurse ranged from 1.5 to 2.6 beds per nurse and was significantly higher both for patients who acquired MSSA ( ) and for patients who acquired MRSA ( ), P p .01 P p .05 compared with the number of beds per nurse for patients who remained uncolonized throughout the ICU stay ( Table  3 ). The mean number of hand disinfectant doses used per bed per day ranged from 27 to 97 doses. The number of doses was not significantly related to MRSA acquisition. However, the number of doses was significantly lower for patients who acquired MSSA than it was for patients who remained uncolonized ( ). P p .02 Patients whose test results remained negative for S. aureus had a mean duration of ICU stay of 10.3 days (range, 8.0-12.9 days), whereas patients who acquired S. aureus in the ICU remained hospitalized in the ICU for a mean of 19.1 days (range, 10.2-30.8 days). Patients who were colonized with S. aureus at admission to the ICU remained hospitalized in the ICU for a mean of 10.7 days (range, 7.4-19.4 days). The mean LOS prior to acquisition (LOS at risk) was 8.3 days for patients with MSSA and 6.9 days for patients with MRSA. The difference in LOS at risk between patients who acquired and patients who did not acquire S. aureus was significant for patients with MSSA ( ) and for pa-P p .001 tients with MRSA ( ). P p .001 The rate of MSSA acquisition was not lower in ICUs in which all patients were treated in private rooms, compared with the rate in ICUs in which not all patients were treated in isolation (Table 3) . However, the number of MRSA acquisitions was significantly lower ( ) in ICUs in which P p .03 all patients were treated in private rooms. cross-tabulation between ICU set-up 1 and 2. c Data given for patients without acquisition is the mean number of patients colonized throughout the study period; data given for patients with acquisition is the mean number of colonized patients in the 3 days preceding acquisition. d During the at-risk period.
Genotyping. All strains were genotyped ( Table 4 ). The total number of spa types found was 119. The total number of MLVA types found was 237. Ten isolates were not typeable by spa typing. All strains were typeable by MLVA typing. The total number of cases of possible patient-to-patient crosstransmission was 18. The percentage of cases of acquisition that could be related to patient-to-patient cross-transmission ranged from 22% to 67% between the participating centers. In center 6, no cases of acquisition and, therefore, no cases of cross-transmission occurred.
Cross-transmission possibly accounted for 40% of all S. aureus acquisitions in the ICUs studied. In 8 of these 18 cases, the possibly cross-transmitted pathogen was MRSA (Table 5 ). In centers 1 and 2, no MRSA was transmitted. Six of the 8 cross-transmitted MRSA strains were found in center 3. They were spa types t032, t1474, and t2577 (both of the last 2 spa types were genetically related to t032) and were closely related in MLVA type. In center 4, 1 MRSA strain was possibly crosstransmitted; this strain was not typeable by spa typing. However, it was identical in MLVA type to an MRSA strain found in a patient who was admitted to the ICU on the same day; this strain was also not typeable by spa typing. The crosstransmitted MRSA isolate at center 5 was also not typeable by spa typing; transmission assessment was based on MLVA typing. The transmitted MRSA strains from different centers were not similar in MLVA type.
In centers 1 and 2, no MRSA isolates were acquired. The cross-transmitted MSSA isolates were spa types t002, t1889, and t015 (which were unrelated spa types) in center 1. The isolates were not related in MLVA type. In center 2, acquired strains were t068, t012, and a nontypeable strain. The acquired t068 strain cross-transmitted to another patient. In center 4, cross-transmitted MSSA isolates were spa types t012, t238, and t084. One t084 isolate was acquired and crosstransmitted to another patient. In center 5, a t645 MSSA isolate was acquired and cross-transmitted to another patient. (44) a Number of isolates that were nontypeable by spa typing. discussion Considerable differences have been reported regarding rates of acquisition and transmission of S. aureus in ICUs and the efficacy of intervention measures. 16, 42 The contribution of variations in sampling and culturing methods to these differences is not clear. In this study, we have assessed the acquisition of S. aureus in different European ICUs using a uniform study protocol to enable a reliable comparison between different ICUs. Antibiotic pressure has been described as a risk factor for the acquisition of MRSA 9, 10 , and the use of antibiotics during and prior to hospitalization in the ICU has been shown to increase the number of MRSA infections. 12, 13, 28 Our results do not show an increased risk of acquiring S. aureus colonization if antibiotics are administered during hospitalization in the ICU, even though only the at-risk period was taken in account. We could not show 1 or more individual types of antibiotics to be strongly related to the increased risk of acquisition. Unfortunately, the information on the antimicrobial agents that were administered to the patients who tested negative for S. aureus colonization throughout the study period was not obtained for 2 centers and therefore could not be evaluated.
It is generally accepted that a greater LOS in an ICU is correlated with a greater likelihood acquisition of MRSA. However, Grundmann et al. 29 did not show that an increased LOS prior to acquisition of MRSA was associated with acquisition of MRSA. This is in agreement with our results, because we also did not find a correlation between LOS prior to acquisition of S. aureus and acquisition of S. aureus. Remarkably, patients who were already colonized with S. aureus when admitted to the ICU had a mean total LOS of 10.7 days, which was comparable with the mean total LOS for patients who did not become colonized (10.3 days). However, patients who acquired MSSA or MRSA during their ICU stay had a mean total LOS of 18.7 and 20.0 days, respectively. This could be explained by the fact that patients with a poorer health status (lower Acute Physiology and Chronic Health Evaluation II score and lower Simplified Acute Physiology Score II) and therefore a longer LOS are at greater risk of acquiring S. aureus, as has previously been shown for MRSA. 8, 18, 29 The mean LOS described in our results is relatively high. This can be explained by the fact that patients who did not have at least 1 follow-up swab sample obtained to assess acquisition were excluded from this evaluation.
Colonization pressure has been shown to be strongly related to the acquisition of MRSA in some studies 8 and has been shown not to be related in other studies. 15, 27 In our study, colonization pressure within an ICU significantly correlated with a higher rate of acquisition both for MSSA and for MRSA. The variability of these results regarding colonization pressure may be explained by difference in the methods used for calculating colonization pressure.
A statistically significant correlation was found between the number of beds per nurse and the acquisition of MSSA and MRSA. Dancer et al. 27 reports on an increase in the number of instances of acquisition of MRSA during a deficit of trained nurses on the ICU, and general nurse workload has been shown to be related to the number of infections and deaths attributable to MRSA. 26 To obtain an estimate of the level of hand hygiene compliance in the different ICUs, the number of doses of hand disinfectant used per bed per day was assessed. Individual hand disinfection compliance was not investigated further, because to do so could have lead to questionable results because of a lack of objective measurements and the Hawthorne effect. 43 The amount of hand disinfectant used per bed per day varied by a factor of 3.6, and use of a lesser amount correlated with a higher number of cases of MSSA acquisition. However, the amount of hand disinfectant used was not statistically significantly related to the number of cases of MRSA acquisition. The wide variation in the amount of hand disinfectant used in the different ICUs cannot be explained and clearly indicates a possible deficiency in the method that we used.
A reduction in the rate of MRSA acquisition through isolation treatment of colonized patients has been postulated in several studies. [44] [45] [46] [47] [48] Nevertheless, a meta-analysis did not show indisputable evidence that isolation treatment of colonized patients leads to a reduced rate of MRSA acquisition. 16 Our results show that the rate of acquisition of MRSA was lowest on an ICU in which all patients were treated in private rooms. This result was not shown for MSSA. Our result is in agreement with a study that showed that no cases of MRSA acquisition and 2 cases of MSSA acquisition occurred in a private-room ICU. 31 The total number of possible cross-transmissions in our study was comparable to the results found in similar studies. 23, 24 However, these studies assessed MRSA only. In our results, the number of cases of patient-to-patient transmission of MRSA was relatively low; in addition, 6 of 8 possible cases were found in a single center, where an endemic MRSA-15, spa type 032 clone is endemic. 49 This clone was found in all possible cases of cross-transmission, probably leading to an overestimation of the number of cases of MRSA cross-transmissions. No outbreak was seen during the study period, because the number of MRSA carriers found did not differ from the number described previously. 49 The number of cases of cross-transmission of MSSA strains was comparable to the number of cases of MRSA cross-transmission. No single spa genotype was found to be predominant among the cases of MSSA cross-transmission, although in center 1, spa type t002 was found in 3 of 5 isolates obtained from patients with cross-transmitted strains. Because these isolates were not related by MLVA type, this cannot be interpreted as an outbreak strain, which demonstrates the relevance of MLVA typing in conjunction with spa typing in a clinical situation.
The present study has a number of limitations. The most important of these is the relatively short period of inclusion at each center and, as a result, the low number of cases of acquisition. This has, unfortunately, led to a questionable multivariate analysis because of underpowering. In addition, a number of patient characteristics were not taken into account. Confounders in this study could include the "average health status" of patients in the different ICUs. The number of surgical patients and of patients receiving mechanical ventilation could also influence the acquisition rate in an ICU. 18, 50 In summary, the impact of LOS prior to acquisition of S. aureus and antibiotic pressure prior to acquisition of S. aureus on rates of acquisition in the ICU could not be demonstrated. Colonization pressure, the number of beds per nurse, and the treatment of all patients in private rooms correlated with the number of cases of acquisition in an ICU. Hand disinfectant use was correlated with MSSA acquisition but not MRSA acquisition. Rates of patient-to-patient cross-transmission were comparable between MSSA and MRSA.
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